Quantcast

Industry news that matters to you.  Learn more

New Salimetrics Salivary IL-1 Beta Immunoassay Kit

Salimetrics has completed development of an immunoassay kit that is fully validated for the measurement of interleukin-1 beta (IL-1 beta) in saliva samples.

NHI to Support Biomarker Discovery for Phase II Parkinson’s Disease Clinical Trials

Last month, the National Institutes of Health announced that the National Institute of Neurological Disorders and Stroke (NINDS) will support hypothesis driven clinical research to discover biomarkers that will improve the efficiency and outcome of Phase II clinical trials for Parkinson’s Disease (PD) and support the collection of clinical data and new biological specimens that will be used for biomarker exploratory efforts under the NINDS Parkinson’s Disease Biomarkers Program (PDBP).

Karolinska Institutet Coordinates International Research on Neurodegenerative Diseases

Karolinska Institutet has been selected to coordinate a major EU research project on neurodegenerative diseases involving 22 countries and a total budget of over 90 million kronor.

VTT Searches for Novel Biomarkers and Targets for Preventing or Treating Type 2 Diabetes

VTT Technical Research Centre of Finland is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.

NIH to Support Clinical Utility Validation of New Molecular Diagnostic Tests

The National Institutes of Health announced yesterday that the National Cancer Institute will support applications to perform validation of the clinical usefulness of new molecular diagnostics for prognosis or prediction of the response to therapy for cancer.